Morvarid Mohseni

Morvarid (Mori) Mohseni currently serves as the Vice President and Head of Biology at VidaVinci, Inc. since June 2025. Mori has held significant positions in the biotechnology and pharmaceutical sectors, including Executive Director of Biological Sciences at Kymera Therapeutics from October 2023 to June 2025, and Director of Oncology Drug Discovery at Bristol Myers Squibb from May 2020 to October 2023. Previous roles at Bristol included Associate Director of Oncology Discovery Pharmacology and In vivo Biology. At Novartis Institutes for BioMedical Research, Mori advanced through various roles, culminating as Senior Principal Scientist in Oncology Drug Discovery. Early career experience includes a position as Senior Scientist at AstraZeneca. Mori holds a Ph.D. in Pharmacology from the University of Illinois College of Medicine and completed a fellowship at Harvard University in Hematology/Oncology and Stem Cell & Regenerative Biology.